GUERBET (GBT.PA) Stock Fundamental Analysis
EPA:GBT - FR0000032526 - Common Stock
19.56 EUR
+0.16 (+0.82%)
Taking everything into account, GBT scores 5 out of 10 in our fundamental rating. GBT was compared to 58 industry peers in the Health Care Equipment & Supplies industry. GBT has only an average score on both its financial health and profitability. GBT has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
GBT had positive earnings in the past year.
GBT had a positive operating cash flow in the past year.
Of the past 5 years GBT 4 years were profitable.
Each year in the past 5 years GBT had a positive operating cash flow.
1.2 Ratios
The Return On Assets of GBT (1.55%) is comparable to the rest of the industry.
GBT has a Return On Equity (4.08%) which is comparable to the rest of the industry.
GBT's Return On Invested Capital of 4.48% is in line compared to the rest of the industry. GBT outperforms 46.55% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GBT is below the industry average of 8.86%.
The 3 year average ROIC (4.08%) for GBT is below the current ROIC(4.48%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 4.08% | ||
| ROIC | 4.48% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
1.3 Margins
GBT's Profit Margin of 1.91% is in line compared to the rest of the industry. GBT outperforms 44.83% of its industry peers.
In the last couple of years the Profit Margin of GBT has declined.
The Operating Margin of GBT (5.89%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of GBT has declined.
GBT has a Gross Margin of 77.94%. This is amongst the best in the industry. GBT outperforms 87.93% of its industry peers.
In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.89% | ||
| PM (TTM) | 1.91% | ||
| GM | 77.94% |
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
GBT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GBT has about the same amout of shares outstanding than it did 1 year ago.
GBT has more shares outstanding than it did 5 years ago.
GBT has a worse debt/assets ratio than last year.
2.2 Solvency
GBT has an Altman-Z score of 2.16. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
GBT has a Altman-Z score of 2.16. This is comparable to the rest of the industry: GBT outperforms 51.72% of its industry peers.
The Debt to FCF ratio of GBT is 16.18, which is on the high side as it means it would take GBT, 16.18 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 16.18, GBT is in line with its industry, outperforming 46.55% of the companies in the same industry.
A Debt/Equity ratio of 0.89 indicates that GBT is somewhat dependend on debt financing.
GBT's Debt to Equity ratio of 0.89 is on the low side compared to the rest of the industry. GBT is outperformed by 77.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | 16.18 | ||
| Altman-Z | 2.16 |
ROIC/WACC0.67
WACC6.69%
2.3 Liquidity
GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
GBT has a better Current ratio (2.32) than 68.97% of its industry peers.
GBT has a Quick Ratio of 1.13. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of GBT (1.13) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
GBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.20%.
GBT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.50% yearly.
Looking at the last year, GBT shows a small growth in Revenue. The Revenue has grown by 7.05% in the last year.
GBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.59% yearly.
EPS 1Y (TTM)-34.2%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-77.4%
Revenue 1Y (TTM)7.05%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%3.65%
3.2 Future
The Earnings Per Share is expected to grow by 6.72% on average over the next years.
The Revenue is expected to grow by 3.59% on average over the next years.
EPS Next Y-25.91%
EPS Next 2Y-0.49%
EPS Next 3Y6.72%
EPS Next 5YN/A
Revenue Next Year2.48%
Revenue Next 2Y3.21%
Revenue Next 3Y3.59%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 15.40, GBT is valued correctly.
93.10% of the companies in the same industry are more expensive than GBT, based on the Price/Earnings ratio.
GBT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.44.
The Price/Forward Earnings ratio is 10.26, which indicates a very decent valuation of GBT.
GBT's Price/Forward Earnings ratio is rather cheap when compared to the industry. GBT is cheaper than 93.10% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of GBT to the average of the S&P500 Index (22.87), we can say GBT is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.4 | ||
| Fwd PE | 10.26 |
4.2 Price Multiples
93.10% of the companies in the same industry are more expensive than GBT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, GBT is valued cheaper than 94.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.2 | ||
| EV/EBITDA | 3.9 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.49%
EPS Next 3Y6.72%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.69%, GBT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.16, GBT pays a better dividend. On top of this GBT pays more dividend than 89.66% of the companies listed in the same industry.
GBT's Dividend Yield is comparable with the S&P500 average which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
5.2 History
The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
GBT pays out 39.20% of its income as dividend. This is a sustainable payout ratio.
DP39.2%
EPS Next 2Y-0.49%
EPS Next 3Y6.72%
EPA:GBT (9/11/2025, 7:00:00 PM)
19.56
+0.16 (+0.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners18.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap247.24M
Analysts75
Price Target26.78 (36.91%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP39.2%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.67%
PT rev (3m)-3.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-24.65%
EPS NY rev (3m)-24.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.4 | ||
| Fwd PE | 10.26 | ||
| P/S | 0.29 | ||
| P/FCF | 10.2 | ||
| P/OCF | 3.04 | ||
| P/B | 0.63 | ||
| P/tB | 0.86 | ||
| EV/EBITDA | 3.9 |
EPS(TTM)1.27
EY6.49%
EPS(NY)1.91
Fwd EY9.75%
FCF(TTM)1.92
FCFY9.8%
OCF(TTM)6.43
OCFY32.85%
SpS66.54
BVpS31.19
TBVpS22.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 4.08% | ||
| ROCE | 6.33% | ||
| ROIC | 4.48% | ||
| ROICexc | 5.17% | ||
| ROICexgc | 6.14% | ||
| OM | 5.89% | ||
| PM (TTM) | 1.91% | ||
| GM | 77.94% | ||
| FCFM | 2.88% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexcg growth 3Y-4.82%
ROICexcg growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | 16.18 | ||
| Debt/EBITDA | 2.86 | ||
| Cap/Depr | 77.91% | ||
| Cap/Sales | 6.78% | ||
| Interest Coverage | 2.42 | ||
| Cash Conversion | 66.19% | ||
| Profit Quality | 150.63% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 2.16 |
F-Score5
WACC6.69%
ROIC/WACC0.67
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.2%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-77.4%
EPS Next Y-25.91%
EPS Next 2Y-0.49%
EPS Next 3Y6.72%
EPS Next 5YN/A
Revenue 1Y (TTM)7.05%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%3.65%
Revenue Next Year2.48%
Revenue Next 2Y3.21%
Revenue Next 3Y3.59%
Revenue Next 5YN/A
EBIT growth 1Y28.18%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year108.81%
EBIT Next 3Y33.55%
EBIT Next 5YN/A
FCF growth 1Y182.76%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y196.03%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%